Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
NCT00149266 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 167
Last updated 2009-02-03
Summary
To compare left thoraco-abdominal approach with abdominal and transhiatal approach to cardia or subcardia cancer
Conditions
- Gastric Neoplasm
Interventions
- PROCEDURE
-
Surgery: abdominal and transhiatal approach
- PROCEDURE
-
Surgery: left thoraco-abdominal approach
Sponsors & Collaborators
-
Ministry of Health, Labour and Welfare, Japan
collaborator OTHER_GOV -
Japan Clinical Oncology Group
lead OTHER
Principal Investigators
-
Mitsuru Sasako, MD · Gastric Surgery Division, National Cancer Center Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-07-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- Japan
More Related Trials
-
Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer
NCT01463501 ·Status: UNKNOWN ·Phase: PHASE2
-
Esophagectomy in Middle and Lower Thoracic Esophageal Cancer Patients Through Left Versus Right Transthoracic Approach
NCT02448979 ·Status: UNKNOWN ·Phase: PHASE3
-
Robot-assisted Thoraco-laparoscopic Esophagectomy Versus Open Transthoracic Esophagectomy
NCT01544790 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus
NCT01225523 ·Status: COMPLETED ·Phase: PHASE1
-
Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer
NCT04688801 ·Status: RECRUITING ·Phase: NA
-
Surgery or Chemoradiation for Esophageal Cancer
NCT01032967 ·Status: COMPLETED ·Phase: PHASE3
-
Right Versus Left Thoracic Surgical Approaches for Siewert II Gastroesophageal Junction Adenocarcinoma
NCT06644352 ·Status: RECRUITING ·Phase: NA
-
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
NCT06060106 ·Status: COMPLETED
-
Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction
NCT04910789 ·Status: RECRUITING ·Phase: NA
-
Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)
NCT06668454 ·Status: RECRUITING ·Phase: NA
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA
-
Quality of Life Outcomes Following Minimally Invasive and Open Esophagectomy for Esophageal Cancer
NCT01558648 ·Status: COMPLETED
-
Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer
NCT07104838 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer
NCT06879483 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy
NCT05105945 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
NCT00047112 ·Status: COMPLETED ·Phase: PHASE3
-
China Early Esophageal Cancer Cohort
NCT06515964 ·Status: RECRUITING
-
Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery
NCT03604991 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer
NCT01998230 ·Status: COMPLETED ·Phase: PHASE3
-
PhaseⅠ/Ⅱ Study of URLC10-177 and TTK-567 Peptide Vaccine Combined With CpG7909 in Patients With Esophageal Cancer
NCT00669292 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
NCT07317609 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
NCT01523015 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT05420480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Safety Study of Multiple Peptide Vaccine to Esophageal Cancer
NCT00561275 ·Status: COMPLETED ·Phase: PHASE1